RxDoctor Payments Data

Marjorie Anderson, MD

Family Medicine · Albuquerque, NMNPI 1750364048

Payments from drug & device makers

$1,759in general payments, 2019–2025

Across 107 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$265
  • Amgen$264
  • Novo Nordisk$243
  • AstraZeneca$221
  • GSK$191
  • Pfizer$81
  • plus $494 from 13 others

What the payments were for

  • Food & beverage$1,759100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,759 in reported general payments places this provider in the 85th percentile of 717 family medicine providers in New Mexico.

See all family medicine providers in New Mexico

Medicare billing

Part B allowed, 2024
$32,588
Medicare patients
163
Services billed
458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide23$33,556
JanuviaSitagliptin Phosphate14$18,096
Stiolto RespimatTiotropium Br/Olodaterol Hcl15$10,352
Atorvastatin Calcium503$9,703
Spiriva HandihalerTiotropium Bromide14$9,619
SymbicortBudesonide/Formoterol Fumarate22$7,281
Levothyroxine Sodium354$5,466
Arnuity ElliptaFluticasone Furoate13$4,151
Gabapentin270$3,784
Lisinopril240$3,475
Losartan Potassium187$3,079
Albuterol Sulfate HfaAlbuterol Sulfate72$2,962
Famotidine172$2,678
DuleraMometasone/Formoterol11$2,550
Tamsulosin Hcl99$2,491

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$243$33,55623 claims
MerckJanuvia, Dulera$27$20,64725 claims
Boehringer IngelheimStiolto Respimat$50$10,35215 claims
AstraZenecaSymbicort$221$7,28122 claims
GSKArnuity Ellipta$191$4,15113 claims
AbbVieSynthroid$38$99532 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 717 family medicine providers in New Mexico.

Other family medicine in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →